Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001193125-18-255518
Filing Date
2018-08-23
Accepted
2018-08-23 06:22:28
Documents
4

Document Format Files

Seq Description Document Type Size
1 F-3/A d875040df3a.htm F-3/A 318516
2 EX-23.2 d875040dex232.htm EX-23.2 1778
3 GRAPHIC g875040dsp03.jpg GRAPHIC 4801
4 GRAPHIC g875040g0716082134208.jpg GRAPHIC 4104
  Complete submission text file 0001193125-18-255518.txt   333902
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: F-3/A | Act: 33 | File No.: 333-226240 | Film No.: 181033635
SIC: 2834 Pharmaceutical Preparations